The Holiday Season, Black Friday and AAPL’s Chances


This Week’s Stock Market Video

The Holiday Season, Black Friday and AAPL’s Chances

Proper Prior Preparation Prevents Poor Performance

In Case You Missed It


It's obviously a tumultuous market environment, so in this week's video Mike Cintolo takes a few extra minutes to detail his current stance and to offer advice depending on your portfolio's current cash level. He also offers guidance on shorting (if that's your cup of tea) and on building your watch list, looking for "early-stage stocks." Names mentioned include: (CRM), Oasis Petroleum (OAS), Financials Sector SPDR (XLF), Alaska Airlines (ALK) and Qihoo 360 (QIHU). Click below to watch the video!

stock market video, mike cintolo, cabot heritage corporation

The Holiday Season, Black Friday and AAPL’s Chances

The markets are doing a fine job of encouraging investors to contemplate less hazardous pastimes … like bungee jumping without elastic cords, for instance, or removing your own appendix. (The final instruction in the Acme Home Appendix Removal Kit is “Suture self.”) At least in bungee jumping (the kind with the cords), you have a reasonable expectation that your free fall will be arrested before you splat into the ground.

But today, with Thanksgiving just six days away, I want to say a brief word about “The Holiday Season,” in general and “Black Friday” in particular.

The Holiday Season is shorthand for the period from Thanksgiving to New Years Day. This year, that will be 41 days, which is as long as it can ever be, given that Thanksgiving will be celebrated at its earliest possible date this year.

It used to be that grumpy social observers would decry the steady creep of the Christmas shopping season to earlier in the year. But once Christmas advertising galloped past Thanksgiving, the only check on its spread into October was Halloween, and that bastion was overrun years ago. Now, the only check on the proliferation of commercials with sleigh bells and holly into September is the sense of shame of marketing managers, and we all know that marketing people get their anti-shame inoculations every September.

Fortunately, I’m not a grumpy social observer, so you’re spared that annoyance.

For genuine cynics, Thanksgiving, Christmas and New Year’s look like shorthand for (respectively) gluttony, greed and drunkenness. But I won’t go there either.

As a stock investor, the Holiday Season looks like a giant reality check on the mood of consumers. Healthy holiday sales can make a huge difference in the lives of retailers, and the stock market will pay very close attention to shopping numbers, both as they come in week-by-week and as they show up in Q4 and year-end reports.

Black Friday, a term coined in the early 1950s to refer to the wave of absenteeism from American factories on the day after Thanksgiving, has now come to mean the biggest shopping day of the year. That’s a change from the old pattern in which sales would gradually increase as December wore on, with the peak shopping coming on the day before Christmas, when desperate and clueless husbands and fathers would descend on stores in a panic and decide that expensive was better than cheap if you didn’t really know what the woman in your life might want.

I respect the Holiday Season for its economic impact. But I love it for other reasons, which I will lay out in future issues.

Today, I want to end with a prediction. Apple (AAPL) was trading right at 700 in September, but fell out of favor with institutional investors after a so-so (for Apple) earnings report. So on Friday, the stock was in exactly the same position as a bungee jumper, poised above 500 with its price in free fall and not sure if its bungee cords were actually hooked to anything.

My prediction is that AAPL—which has fallen so low that it was just featured in the November issue of Cabot Ben Graham Value Letter, which admired its projected earnings growth (22% per year for the next five years), forward P/E ratio (11.1) and newly instituted dividend—will come roaring back quickly.

This isn’t an investment recommendation; Cabot growth disciplines don’t have any place for hunches. But the market is known for overreacting, and AAPL below 500 makes no more sense to me than AAPL above 700.

So don’t buy AAPL on my account. But put it on a Post-It that Paul Goodwin says that AAPL will rise again. We can check on how well my prognosticator works as the Holiday Season progresses.

Here's this week's Contrary Opinion Button. Remember, you can always view all of the buttons by clicking here.

Cabot Heritage CorporationProper Prior Preparation Prevents Poor Performance

Tim’s comment: It has the same number of “Ps” as “Peter Piper picked a peck of pickled peppers,” as well as no words that don’t start with “P.” And it touts the value of preparation. Can’t argue with that.

Paul’s comment: I think Tim nailed this one. All I can add is that my favorite version of this saying is in the form of a smart-alecky addition to “Practice makes perfect.” To that, a Vince Lombardi would have added “… if practice is perfect.”

Like the 974% Gains We Made in Monster Beverage

If you always wanted to test-drive our Cabot Small-Cap Confidential advisory, today is the day.

We're recommending a breakthrough $20 biotech stock that our research shows could hit $40 in the next 12 months--with 20% to 30% gains coming in the next 30 days.

The stock's share price is already up 116% and looks to be rising faster than the 974% we made in Monster Beverage a few years back.

In fact, I so strongly believe that this new recommendation could ultimately become our next Monster Beverage, I want to give you the name of this company free along with a money-back trial subscription to Cabot Small-Cap Confidential.

You'll get not only the full story on this fast moving biotech stock but also on 15 more game-changers that could hand you money-doubling profits— and then some—over the next 12 months.


In case you didn't get a chance to read all the issues of Cabot Wealth Advisory this week and want to catch up on any investing and stock tips you might have missed, there are links below to each issue.

Cabot Wealth Advisory 11/12/12 — The Ten Best Dividend Paying Companies

Cabot Ben Graham Value Letter editor Roy Ward talks about the importance of dividends for value investors and offers a new list of the ten best dividend-paying companies. Stocks discussed: Accenture Plc. (ACN) and CVS Caremark (CVS). 

Cabot Wealth Advisory 11/13/12 — Get-Rich Stocks and Stay-Rich Stocks

Tim Lutts, Cabot’s fearless leader and editor of Cabot Stock of the Month, writes about the stocks that let rich people hold onto their money and the stocks that those of us who would like to be rich can use to get their. Tim offers a special report detailing five stocks with huge potential. You can get it by using this link. He also discusses International Business Machines (IBM), a stay-rich stock. 

Cabot Wealth Advisory 11/15/12 — How is Skee-Ball Like Investing?

This issue features a repeat engagement with Chloe Lutts’ essay on the parallel between risk and return in Skee-Ball and investing. And I point out that market timing is the biggest risk-control tactic of all. Stock discussed: Deutsche Bank (DB).

Have a great weekend,

Paul Goodwin

Editor of Cabot Wealth Advisory
and Cabot China & Emerging Markets Report

Editor's Note: Paul Goodwin’s Cabot China & Emerging Markets Report is the place to discover the top stocks in fast-growing international emerging market sector. Learn more here about high-potential stocks like NTE, PSMT, MPEL and CHL, and the proper way to handle them.


Sign Up Free for the Cabot Wealth Advisory Here!

Paul Goodwin can be found on Google Plus.

Stock Picks


This stock could rise 50% before becoming fairly valued.

This hot technology company is growing like a weed, thanks to products that speed up cloud communications.

This stock is somewhat well known, but far from well loved.

Cabot Wealth Advisory

How to Find Great Growth Stocks in a Scary Market

By Paul Goodwin on October 21, 2016

Even in today’s scary market, there are great growth stocks out there. Here’s how to find them—and how to avoid the kind of losses that can haunt your portfolio.Read More >

Buy This Small-Cap Tech Stock as the Nasdaq Thrives

By Tyler Laundon on October 20, 2016

Technology stocks are thriving, as the Nasdaq has been outpacing the S&P 500 and the Dow for months. And one small-cap tech stock in particular is outperforming the industry’s big boys. Read More >

Is Allergan (AGN) Still an Undervalued Stock?

By Crista Huff on October 18, 2016

Five months ago, Allergan (AGN) was an undervalued stock with tons of growth potential. It's up 21% since then, but still has plenty of upside. Here's why.Read More >